Definitive Healthcare (NASDAQ:DH) Shares Up 6.8% – Time to Buy?

Definitive Healthcare Corp. (NASDAQ:DH)’s share price shot up 6.8% during trading on Tuesday . The company traded as high as $4.91 and last traded at $4.94. 899,586 shares were traded during trading, an increase of 15% from the average session volume of 781,061 shares. The stock had previously closed at $4.62.

Wall Street Analysts Forecast Growth

DH has been the subject of a number of recent analyst reports. Needham & Company LLC reissued a “hold” rating on shares of Definitive Healthcare in a report on Thursday, January 16th. Barclays reiterated an “underweight” rating and set a $4.00 price objective on shares of Definitive Healthcare in a research note on Monday, January 13th. Finally, Stephens assumed coverage on shares of Definitive Healthcare in a research report on Friday, December 20th. They issued an “equal weight” rating and a $5.00 target price for the company. Two equities research analysts have rated the stock with a sell rating, six have issued a hold rating and three have issued a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $5.72.

Definitive Healthcare Trading Down 0.2 %

The business’s 50 day moving average price is $4.41 and its two-hundred day moving average price is $4.45. The company has a market capitalization of $568.36 million, a price-to-earnings ratio of -1.59, a P/E/G ratio of 3.54 and a beta of 1.41. The company has a current ratio of 2.49, a quick ratio of 2.49 and a debt-to-equity ratio of 0.33.

Definitive Healthcare (NASDAQ:DH) last issued its earnings results on Thursday, November 7th. The company reported $0.05 earnings per share for the quarter, missing analysts’ consensus estimates of $0.08 by ($0.03). The company had revenue of $62.70 million during the quarter, compared to analyst estimates of $61.66 million. Definitive Healthcare had a negative net margin of 142.38% and a positive return on equity of 1.76%. During the same quarter in the prior year, the business earned $0.01 EPS. On average, equities analysts predict that Definitive Healthcare Corp. will post 0.15 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, insider William Moschella sold 45,000 shares of Definitive Healthcare stock in a transaction on Tuesday, December 3rd. The shares were sold at an average price of $4.70, for a total transaction of $211,500.00. Following the transaction, the insider now owns 433,830 shares in the company, valued at approximately $2,039,001. The trade was a 9.40 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 14.84% of the company’s stock.

Institutional Trading of Definitive Healthcare

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Massachusetts Financial Services Co. MA raised its stake in Definitive Healthcare by 36.8% during the third quarter. Massachusetts Financial Services Co. MA now owns 6,053,233 shares of the company’s stock worth $27,058,000 after buying an additional 1,626,813 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. acquired a new stake in Definitive Healthcare during the 3rd quarter worth about $512,000. Hennion & Walsh Asset Management Inc. grew its holdings in Definitive Healthcare by 34.1% during the 4th quarter. Hennion & Walsh Asset Management Inc. now owns 50,886 shares of the company’s stock worth $209,000 after acquiring an additional 12,946 shares during the period. State Street Corp raised its position in shares of Definitive Healthcare by 29.4% in the 3rd quarter. State Street Corp now owns 1,399,729 shares of the company’s stock worth $6,257,000 after acquiring an additional 317,952 shares in the last quarter. Finally, Barclays PLC lifted its stake in shares of Definitive Healthcare by 318.8% in the 3rd quarter. Barclays PLC now owns 81,916 shares of the company’s stock valued at $366,000 after purchasing an additional 62,354 shares during the period. 98.67% of the stock is currently owned by institutional investors and hedge funds.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.